Two transgender adolescents and their families are challenging Ohio’s House Bill 68, a law passed in January 2024 that prohibits gender-affirming medical care that is widely accepted to treat gender dysphoria, helping alleviate the distress of gender dysphoria and significantly improving patients’ mental health and well-being. Such treatment is supported by leading medical experts and all major U.S. medical organizations, including the American Medical Association, the American Psychiatric Association, and the American Academy of Pediatrics.

In May 2025, two transgender adolescents and their parents filed a challenge in Kansas state court against SB 63, a state law prohibiting access to gender-affirming medical treatments for transgender people under 18. Access to gender-affirming medical care, such as hormone therapies and pubertal suppressants, for transgender adolescents is supported by the American Medical Association, the American Psychological Association, and the American Academy of Pediatrics.

Following a request from the Office of the Attorney General of Texas for records and documents related to its advocacy on behalf of families with transgender youth, PFLAG National sued to block the request in February 2024. Represented by the American Civil Liberties Union and other LGBTQ legal organizations, PFLAG is also a plaintiff in two lawsuits in Texas relating to gender-affirming care for minors.